Web Desc
The Potent New Anti-Tumor Immunotherapies
Organizer(s): Nicholas P. Restifo
Date: March 28 - April 02, 2007
Location: Fairmont Banff Springs, Banff, AB, Canada
Sponsored by sanofi-aventis
For important information on the coronavirus, please click here
Summary of Meeting:
For the first time, significant numbers of patients with some solid cancer histologies can be successfully treated using immunological means. Progress in our understanding of immune activation, homeostasis and regulation has reached a “tipping point” that has enabled the development of multiple anti-tumor immune-based strategies. Adoptive cell transfer (ACT) of anti-tumor T cells after the depletion host immune cells causes objective regression in about 50% of the patients. Work on therapeutic cancer vaccines is intensive and will actively be discussed at the meeting. The challenge now is to control and direct the potent new weapons in at the immunotherapist’s disposal. This meeting will bring the key scientists who are securing the basic foundations of the new immunology and the translational immunotherapists who are pioneering strategies that objectively work in the clinic.
Scholarship Deadline: November 28 2006
Discounted Abstract Deadline: November 28 2006
Abstract Deadline: January 12 2007
Discounted Registration Deadline: January 29 2007
We gratefully acknowledge additional support for this conference from:
Sanofi US
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1 R13 CA124284-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Wednesday, March 28 | 3:00PM - 7:30PM
Registration
Room: Van Horne Foyer


Wednesday, March 28 | 6:30PM - 7:30PM
Refreshments
Room: Van Horne Foyer


Wednesday, March 28 | 7:30PM - 9:30PM
Keynote Address
Room: Van Horne AB

Speaker 1 of 2
David Baltimore, California Institute of Technology, USA
Engineering Immunity to Cancer and other Diseases

Wednesday, March 28 | 7:30PM - 9:30PM
Keynote Address
Room: Van Horne AB

Speaker 2 of 2
Luigi M. Naldini, San Raffaele Telethon Institute, Italy
Novel Approaches to Regulate Transgene Expression and Enhance the Efficacy and Safety of Gene Therapy

Thursday, March 29 | 7:00AM - 8:00AM
Breakfast
Room: Alberta, New Brunswick, Cascade, Conservatory


Thursday, March 29 | 8:00AM - 9:00AM
Morning Lecture
Room: Van Horne AB

Speaker 1 of 1
Steven A. Rosenberg, NCI, National Institutes of Health, USA
Current Immunotherapies Based on Lymphodepletion and Adoptive Cell Transfer

Thursday, March 29 | 9:00AM - 9:20AM
Coffee Break
Room: Van Horne Foyer


Thursday, March 29 | 9:20AM - 11:15AM
Adoptive Immunotherapy
Room: Van Horne AB

Speaker 1 of 3
Malcolm K. Brenner, Baylor College of Medicine, USA
Adoptive Immunotherapy of EBV-Associated Malignancies with EBV-Specific Cytotoxic T-Cell Lines

Thursday, March 29 | 9:20AM - 11:15AM
Adoptive Immunotherapy
Room: Van Horne AB

Speaker 2 of 3
Philip D. Greenberg, University of Washington, USA
Engineering T Cells for Adoptive Transfer

Thursday, March 29 | 9:20AM - 11:15AM
Adoptive Immunotherapy
Room: Van Horne AB

Speaker 3 of 3
* James P. Allison, University of Texas MD Anderson Cancer Center, USA
Immune Checkpoint Blockade in Cancer Therapy

Thursday, March 29 | 11:15AM - 1:00PM
Poster Setup
Room: Alberta, New Brunswick, Cascade, Conservatory


Thursday, March 29 | 1:00PM - 10:00PM
Poster Viewing
Room: Alberta, New Brunswick, Cascade, Conservatory


Thursday, March 29 | 2:00PM - 3:30PM
Editor's Forum
Room: Van Horne AB

Speaker 1 of 3
* Linda J. Miller, American Association for Cancer Research, USA
Scientific Journals, Plagiarism and Fraud

Thursday, March 29 | 2:00PM - 3:30PM
Editor's Forum
Room: Van Horne AB

Speaker 2 of 3
Juan Carlos Lopez, Haystack Science, USA
Challenges in Producing (and Publishing) Translational Research

Thursday, March 29 | 2:00PM - 3:30PM
Editor's Forum
Room: Van Horne AB

Speaker 3 of 3
Heather L. Van Epps, Journal of Experimental Medicine, USA
1896: Experimental Medicine Then and Now

Thursday, March 29 | 3:30PM - 4:30PM
Special Lecture
Room: Van Horne AB

Speaker 1 of 1
Dario A. A. Vignali, University of Pittsburgh School of Medicine, USA
Regulatory T Cell Function is Mediated by the Novel Inhibitory Cytokine Interleukin-34

Thursday, March 29 | 4:30PM - 5:00PM
Coffee Available
Room: Van Horne Foyer


Thursday, March 29 | 5:00PM - 7:00PM
Programing of T Cells and Differentiation
Room: Van Horne AB

Speaker 1 of 3
Carl H. June, University of Pennsylvania, USA
Adoptive Immunotherapy: New Ways to Skin the Cat?

Thursday, March 29 | 5:00PM - 7:00PM
Programing of T Cells and Differentiation
Room: Van Horne AB

Speaker 2 of 3
Federica Sallusto, Università della Svizzera Italiana & ETH Zurich, Switzerland
Understanding the Generation and Function of Memory T Cell Subsets

Thursday, March 29 | 5:00PM - 7:00PM
Programing of T Cells and Differentiation
Room: Van Horne AB

Speaker 3 of 3
* Stephen P. Schoenberger, La Jolla Institute for Allergy and Immunology, USA
Programmed Tolerance of CD8+ T Cells by B Cell APC

Thursday, March 29 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Alberta, New Brunswick, Cascade, Conservatory


Thursday, March 29 | 7:30PM - 10:00PM
Poster Session 1
Room: Alberta, New Brunswick, Cascade, Conservatory


Friday, March 30 | 7:00AM - 8:00AM
Breakfast
Room: Alberta, New Brunswick, Cascade, Conservatory


Friday, March 30 | 8:00AM - 9:00AM
Morning Lecture
Room: Van Horne AB

Speaker 1 of 1
Nicholas P. Restifo, Lyell, USA
The Future of Adoptive Immunotherapy

Friday, March 30 | 9:00AM - 9:20AM
Coffee Break
Room: Van Horne Foyer


Friday, March 30 | 9:20AM - 11:30AM
Lymphodepletion
Room: Van Horne AB

Speaker 1 of 4
* Charles D. Surh, La Jolla Institute for Allergy and Immunology, USA
Potentials of T Cell Homeostatic Cytokines

Friday, March 30 | 9:20AM - 11:30AM
Lymphodepletion
Room: Van Horne AB

Speaker 2 of 4
Yang Liu, University of Michigan, Ann Arbor, USA
Short Talk: CD24 Controls T Cell Homeostasis and Cancer Resistance

Friday, March 30 | 9:20AM - 11:30AM
Lymphodepletion
Room: Van Horne AB

Speaker 3 of 4
Hyam I. Levitsky, Century Therapeutics, USA
In vivo Depletion of Immune Regulatory Factors

Friday, March 30 | 9:20AM - 11:30AM
Lymphodepletion
Room: Van Horne AB

Speaker 4 of 4
Stanley R. Riddell, Fred Hutchinson Cancer Research Center, University of Washington, USA
Establishing T Cell Memory by Adoptive Transfer of T Cell Clones

Friday, March 30 | 11:30AM - 1:00PM
Poster Setup
Room: Alberta, New Brunswick, Cascade, Conservatory


Friday, March 30 | 1:00PM - 10:00PM
Poster Viewing
Room: Alberta, New Brunswick, Cascade, Conservatory


Friday, March 30 | 2:00PM - 2:30PM
Special Lecture
Room: Van Horne A/B

Speaker 1 of 1
Robert H. Wiltrout, NCI, National Institutes of Health, USA
Immunotherapy of Cancer by IL12-based Cytokine Combinations

Friday, March 30 | 2:30PM - 4:30PM
Workshop 2A
Room: Van Horne A/B

Speaker 1 of 5
Phillip K. Darcy, Peter MacCallum Cancer Centre, Australia
Investigation of the Role of Gene-Modified CD4+ T Cell Subsets for Cancer Immunotherapy

Friday, March 30 | 2:30PM - 4:30PM
Workshop 2A
Room: Van Horne A/B

Speaker 2 of 5
Wolfgang Uckert, Humboldt-University, Germany
Enhanced Functional Expression of T Cell Receptors by Genetic Modification and Vector Optimization

Friday, March 30 | 2:30PM - 4:30PM
Workshop 2A
Room: Van Horne A/B

Speaker 3 of 5
Jacob Schachter, Sheba Medical Center, Israel
Adoptive Immunotherapy

Friday, March 30 | 2:30PM - 4:30PM
Workshop 2A
Room: Van Horne A/B

Speaker 4 of 5
Antoni Ribas, University of California, Los Angeles, USA
PET Imaging of Adoptive Transfer Immunotherapy

Friday, March 30 | 2:30PM - 4:30PM
Workshop 2A
Room: Van Horne A/B

Speaker 5 of 5
* Michael H. Kershaw, Peter MacCallum Cancer Center, Australia
Targeting a Carbohydrate Antigen using T Cells Modified with a Humanized Chimeric Receptor Gene

Friday, March 30 | 2:30PM - 4:30PM
Workshop 2B
Room: Van Horne C

Speaker 1 of 6
Mary Jo Turk, Dartmouth Hitchcock Medical Center, USA
The Induction of T Cell Memory in the Absence of Tregs after Surgical Excision

Friday, March 30 | 2:30PM - 4:30PM
Workshop 2B
Room: Van Horne C

Speaker 2 of 6
Shimon Slavin, International Center for Cell Therapy & Cancer Immunotherapy, Israel
Cell-Mediated Immunotherapy of Hematological Malignancies and Metastatic Solid Tumors

Friday, March 30 | 2:30PM - 4:30PM
Workshop 2B
Room: Van Horne C

Speaker 3 of 6
Weiping Zou, University of Michigan, USA
Tregs, Th17 and their regulation in the tumor microenvironment

Friday, March 30 | 2:30PM - 4:30PM
Workshop 2B
Room: Van Horne C

Speaker 4 of 6
Sjoerd H. van der Burg, Leiden University Medical Center, Netherlands
Human Tumor-Specific Regulatory T-Cells in Therapeutic Vaccination Strategies

Friday, March 30 | 2:30PM - 4:30PM
Workshop 2B
Room: Van Horne C

Speaker 5 of 6
Jill E. Slansky, University of Colorado Health Sciences Center, USA
Relating TCR-Peptide-MHC Affinity to Immunogenicity

Friday, March 30 | 2:30PM - 4:30PM
Workshop 2B
Room: Van Horne C

Speaker 6 of 6
* Karin U. Jooss, Gritstone Oncology, USA
GM-CSF Transduced Cancer Cell Immunotherapies in Combination with Anti-CTLA4: Of Mice and Men

Friday, March 30 | 4:30PM - 5:00PM
Coffee Available
Room: Van Horne Foyer


Friday, March 30 | 5:00PM - 7:00PM
Triggering Self Recognition
Room: Van Horne AB

Speaker 1 of 4
Pamela S. Ohashi, Princess Margaret Cancer Centre, Canada
Cytokines are critical regulators of anti-tumor immunity

Friday, March 30 | 5:00PM - 7:00PM
Triggering Self Recognition
Room: Van Horne AB

Speaker 2 of 4
Suzanne L. Topalian, Johns Hopkins University School of Medicine, USA
Short Talk: The Hybrid Nature of Altered Self: Structural Basis for MHC Class II-Restricted TCR Recognition of a Mutant Tumor Antigen

Friday, March 30 | 5:00PM - 7:00PM
Triggering Self Recognition
Room: Van Horne AB

Speaker 3 of 4
Elizabeth M. Jaffee, Johns Hopkins University, USA
Tipping the Immune System Balance in Favor of Effective Anti-Cancer Therapy

Friday, March 30 | 5:00PM - 7:00PM
Triggering Self Recognition
Room: Van Horne AB

Speaker 4 of 4
* Linda A. Sherman, The Scripps Research Institute, USA
Immune Tolerance to Persistent Antigens and Dealing with the Consequences for Tumor Immunotherapy

Friday, March 30 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Alberta, New Brunswick, Cascade, Conservatory


Friday, March 30 | 7:30PM - 10:00PM
Poster Session 2
Room: Alberta, New Brunswick, Cascade, Conservatory


Saturday, March 31 | 7:00AM - 8:00AM
Breakfast
Room: Alberta, New Brunswick, Cascade, Conservatory


Saturday, March 31 | 8:00AM - 11:00AM
Dendritic Cells
Room: Van Horne AB

Speaker 1 of 5
* A. Karolina Palucka, The Jackson Laboratory for Genomic Medicine, USA
Understanding the Interplay of the Human Immune System with Cancer in Humanized Mice

Saturday, March 31 | 8:00AM - 11:00AM
Dendritic Cells
Room: Van Horne AB

Speaker 2 of 5
Lieping Chen, Yale University, USA
Co-Stimulatory and Co-Inhibitory Receptor-Ligand Pairs

Saturday, March 31 | 8:00AM - 11:00AM
Dendritic Cells
Room: Van Horne AB

Speaker 3 of 5
Vincenzo Cerundolo, University of Oxford, UK
Harnessing NKT cells in cancer vaccination strategies

Saturday, March 31 | 8:00AM - 11:00AM
Dendritic Cells
Room: Van Horne AB

Speaker 4 of 5
Andrew L. Mellor, Georgia Regents University, USA
Immunoregulatory Plasmacytoid Dendritic Cells Expressing Indoleamine 2,3 Dioxygenase (IDO)

Saturday, March 31 | 8:00AM - 11:00AM
Dendritic Cells
Room: Van Horne AB

Speaker 5 of 5
Patrick Hwu, University of Texas MD Anderson Cancer Center, USA
Short Talk: Use of Activated Plasmacytoid Dendritic Cells to Induce
Antitumor Immunity


Saturday, March 31 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Foyer


Saturday, March 31 | 11:00AM - 1:00PM
Poster Setup
Room: Alberta, New Brunswick, Cascade, Conservatory


Saturday, March 31 | 1:00PM - 10:00PM
Poster Viewing
Room: Alberta, New Brunswick, Cascade, Conservatory


Saturday, March 31 | 2:00PM - 2:30PM
Special Lecture
Room: Van Horne AB

Speaker 1 of 1
Vincenzo Bronte, University of Verona, Italy
Myeloid Suppressor Cells in Cancer

Saturday, March 31 | 2:30PM - 4:30PM
Workshop 3A
Room: Van Horne A/B

Speaker 1 of 5
Franck Housseau, Johns Hopkins School of Medicine, USA
Interferon-Producing Killer Dendritic Cells

Saturday, March 31 | 2:30PM - 4:30PM
Workshop 3A
Room: Van Horne A/B

Speaker 2 of 5
Naoto Hirano, Princess Margaret Cancer Centre, Canada
IL-21 Mediated Expansion of Antigen-Speciific CD8+ T Cells

Saturday, March 31 | 2:30PM - 4:30PM
Workshop 3A
Room: Van Horne A/B

Speaker 3 of 5
Diana F. Hausman, Zymeworks, USA
Clinical Studies of IL-21 in the Immunotherapy of Cancer

Saturday, March 31 | 2:30PM - 4:30PM
Workshop 3A
Room: Van Horne A/B

Speaker 4 of 5
Reno Debets, Erasmus MC Cancer Institute, Netherlands
IL-21 Promotes Naieve T Cell Phenotype and Antigen-Specific Functions in TCR-Transduced T Cells

Saturday, March 31 | 2:30PM - 4:30PM
Workshop 3A
Room: Van Horne A/B

Speaker 5 of 5
* Gosse J. Adema, University Medical Center, NCMLS Nijmegen, Netherlands
The Impact of Toll-Like Receptors on Regulatory T Cells

Saturday, March 31 | 2:30PM - 4:30PM
Workshop 3B
Room: Van Horne C

Speaker 1 of 6
Peter P. Lee, Stanford University School of Medicine, USA
Downregulation of Interferon-Signaling Pathways in Lymphocytes from Metastatic Melanoma Patients

Saturday, March 31 | 2:30PM - 4:30PM
Workshop 3B
Room: Van Horne C

Speaker 2 of 6
Paul R. Walker, Geneva University Hospital, Switzerland
Functional Differentiation of CD8 T Cells during the Effector Phase of Brain Tumor Immunity

Saturday, March 31 | 2:30PM - 4:30PM
Workshop 3B
Room: Van Horne C

Speaker 3 of 6
Nathalie Rufer, Swiss Institute for Experimental Cancer Research, Switzerland
In vivo Clonal Distribution and Longevity of Functional Human Tumor Antigen Specific T Cells

Saturday, March 31 | 2:30PM - 4:30PM
Workshop 3B
Room: Van Horne C

Speaker 4 of 6
* George Coukos, University Hospital of Lausanne - CHUV, Switzerland
Regulation of T Cell Trafficking by Tumor Endothelium: Implications for Immunotherapy

Saturday, March 31 | 2:30PM - 4:30PM
Workshop 3B
Room: Van Horne C

Speaker 5 of 6
Mikael J. Pittet, Massachusetts General Hospital, USA
Noninvasive in vivo Assessment of CTL Delivery at the Tumor Site

Saturday, March 31 | 2:30PM - 4:30PM
Workshop 3B
Room: Van Horne C

Speaker 6 of 6
Michelle Krogsgaard, New York University School of Medicine, USA
Imaging Sensitivity of T-Cell Recognition of Melanoma Antigens

Saturday, March 31 | 4:30PM - 5:00PM
Coffee Available
Room: Van Horne Foyer


Saturday, March 31 | 5:00PM - 7:00PM
Visualizing T Cell Target Cell Interactions in Real-Time
Room: Van Horne AB

Speaker 1 of 4
* Mark M. Davis, Stanford University School of Medicine, USA
T Cell Recognition

Saturday, March 31 | 5:00PM - 7:00PM
Visualizing T Cell Target Cell Interactions in Real-Time
Room: Van Horne AB

Speaker 2 of 4
Andrey S. Shaw, Genentech, Inc., USA
Antigen Recognition and Immunological Synapse Formation

Saturday, March 31 | 5:00PM - 7:00PM
Visualizing T Cell Target Cell Interactions in Real-Time
Room: Van Horne AB

Speaker 3 of 4
Alex Y.C. Huang, Case Western Reserve University School of Medicine, USA
Short Talk: Chemokine Guidance of Cellular Cooperation During Primary Adaptive Immune Response

Saturday, March 31 | 5:00PM - 7:00PM
Visualizing T Cell Target Cell Interactions in Real-Time
Room: Van Horne AB

Speaker 4 of 4
Rajat Varma, Xencor Inc., USA
Short Talk: A Dynamic View of the Immunological Synapse

Saturday, March 31 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Alberta, New Brunswick, Cascade, Conservatory


Saturday, March 31 | 7:30PM - 10:00PM
Poster Session 3
Room: Alberta, New Brunswick, Cascade, Conservatory


Sunday, April 01 | 7:00AM - 8:00AM
Breakfast
Room: Alberta, New Brunswick, Cascade, Conservatory


Sunday, April 01 | 8:00AM - 9:00AM
Concluding Keynote Address
Room: Van Horne AB

Speaker 1 of 1
Rafi Ahmed, Emory University School of Medicine, USA
Inducing Functional Immune Responses or CD8 T Cell Memory

Sunday, April 01 | 9:00AM - 9:20AM
Coffee Break
Room: Van Horne Foyer


Sunday, April 01 | 9:20AM - 11:30AM
Genetically Engineering Cells for Adoptive Immunotherapy
Room: Van Horne AB

Speaker 1 of 4
Ton N. Schumacher, Netherlands Cancer Institute, Netherlands
Prospects and Limitations of T Cell Receptor Gene Therapy

Sunday, April 01 | 9:20AM - 11:30AM
Genetically Engineering Cells for Adoptive Immunotherapy
Room: Van Horne AB

Speaker 2 of 4
Ken-ichi Hanada, National Cancer Institute, National Institutes of Health, USA
Short Talk: Genetic Engineering of T Cells for the Recognition of Renal Cell Tumors

Sunday, April 01 | 9:20AM - 11:30AM
Genetically Engineering Cells for Adoptive Immunotherapy
Room: Van Horne AB

Speaker 3 of 4
Juan Carlos Zúñiga-Pflücker, Sunnybrook Research Institute, Canada
From Stem Cells to T-Cells in vitro, a Toolkit for Cellular Immunotherapy

Sunday, April 01 | 9:20AM - 11:30AM
Genetically Engineering Cells for Adoptive Immunotherapy
Room: Van Horne AB

Speaker 4 of 4
Drew M. Pardoll, Johns Hopkins University School of Medicine, USA
Cancer Immunotherapy via Manipulation of T Cell Activation and Tumor Microenvironment

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4A
Room: Van Horne A/B

Speaker 1 of 5
* Lili Yang, California Institute of Technology, USA
Gene Modification of Hematopoietic Stem Cells

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4A
Room: Van Horne A/B

Speaker 2 of 5
Linda Liu, Maxcyte Corp, USA
Genetically Engineering Cells at Industrial Scale for Immunotherapy

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4A
Room: Van Horne A/B

Speaker 3 of 5
Hans J. Stauss, Royal Free College, UK
Exploiting T Cell Receptor Genes for Cancer Immunotherapy

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4A
Room: Van Horne A/B

Speaker 4 of 5
Michel Sadelain, Memorial Sloan Kettering Cancer Center, USA
Novel Genetic Strategies to Enhance T Cell Function

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4A
Room: Van Horne A/B

Speaker 5 of 5
Cyrille J. Cohen, Bar-Ilan University, Israel
Genetically Engineering Human T Cell Receptor Structure

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4B
Room: Van Horne C

Speaker 1 of 7
* Thomas Gajewski, University of Chicago, USA
T Cell Anergy as a Mechanism of Immune Escape

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4B
Room: Van Horne C

Speaker 2 of 7
Charles G. Drake, Columbia University, USA
STAT3 is required for Il-17 and Il-23 in the Tumor Microenvironment

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4B
Room: Van Horne C

Speaker 3 of 7
Pawel Kalinski, University of Pittsburgh, USA
Reciprocal Impact of Effector and Memory CD8+ T Cells on the Effectiveness of Cancer Vaccines

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4B
Room: Van Horne C

Speaker 4 of 7
Mark Selby, Bristol Myers-Squibb, USA
Combination of CTLA-4 and PD-1 Blockade Induces Potent Anti-Tumor Responses

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4B
Room: Van Horne C

Speaker 5 of 7
Martin L. Ashdown, ImmunAid P/L, Australia
Breaking a Deadly Cycle: Succesful Timed Treg Lymphodepletion in Cancer - Is it Already Happening Accidentally in the Oncology Clinic with Standard Drugs?

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4B
Room: Van Horne C

Speaker 6 of 7
Wilfred A. Jefferies, University of British Columbia, Canada
Epigenetic Control of the Immune Escape Mechanisms in Malignant Carcinomas

Sunday, April 01 | 2:00PM - 4:30PM
Workshop 4B
Room: Van Horne C

Speaker 7 of 7
Annette Paschen, University Hospital Essen, Germany
Generation of the Melan-A/MART-1 CTL Epitope - How Cellular Proteases Reduce the Specific T Cell Stimulatory Capacity of Melanoma

Sunday, April 01 | 4:30PM - 5:00PM
Coffee Available
Room: Van Horne Foyer


Sunday, April 01 | 5:00PM - 7:00PM
Future Work for the Clinic
Room: Van Horne AB

Speaker 1 of 3
Rienk Offringa, Genentech Inc., USA
The Potential and Pitfalls of Targeting Cancer through Self-Antigens

Sunday, April 01 | 5:00PM - 7:00PM
Future Work for the Clinic
Room: Van Horne AB

Speaker 2 of 3
Pedro Romero, University of Lausanne, Switzerland
New Clinical Vaccine Trials

Sunday, April 01 | 5:00PM - 7:00PM
Future Work for the Clinic
Room: Van Horne AB

Speaker 3 of 3
* Bruce R. Blazar, University of Minnesota, USA
Umbilical Cord Blood Transplant (UCBT) as a Platform for Inducing Anti-Leukemia Immune Responses

Sunday, April 01 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Alberta, New Brunswick, Cascade, Conservatory


Sunday, April 01 | 8:00PM - 11:00PM
Entertainment
Room: Alberta, New Brunswick, Casade, Conservatory


Sunday, April 01 | 8:00PM - 11:00PM
Cash Bar
Room: Alberta, New Brunswick, Casade, Conservatory


Monday, April 02 | 10:21AM - 10:21AM
Departure


*Session Chair
†Invited, not yet responded.